Article

Circulating ACE2-expressing Exosomes Block SARS-CoV-2 Infection as an Innate Antiviral…

Research square · 2021 · Lamiaa El-Shennawy, author Andrew Hoffmann, author Nurmaa Dashzeveg, author Paul Mehl, author Zihao Yu, author Valerie Tokars, author Carolina Ostiguin, author Yuzhi Jia, author Lin Li, author Chengsheng Mao, author Jan Wysocki, author Daniel Batlle, author Thomas Hope, author Yuan Luo, author Young Chae, author Hui Zhang, author Suchitra Swaminathan, author Alexis Demonbreun, author Michael Ison, author Deyu Fang, author Huiping Liu, author

Key facts

Title Circulating ACE2-expressing Exosomes Block SARS-CoV-2 Infection as an Innate Antiviral Mechanism
First author Lamiaa El-Shennawy, author Andrew Hoffmann, author Nurmaa Dashzeveg, author Paul Mehl, author Zihao Yu, author Valerie Tokars, author Carolina Ostiguin, author Yuzhi Jia, author Lin Li, author Chengsheng Mao, author Jan Wysocki, author Daniel Batlle, author Thomas Hope, author Yuan Luo, author Young Chae, author Hui Zhang, author Suchitra Swaminathan, author Alexis Demonbreun, author Michael Ison, author Deyu Fang, author Huiping Liu, author
Journal Research square
Published Jan 18, 2021
DOI 10.21203/rs.3.rs-141729/v1
Devices mentioned K042152, K940422, K982100
Product codes mentioned CFN, DFZ, JQC, NNL

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature